Masahiro Yokoyama Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

9/2012	Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas.
5/2011	[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Yokoyama Research Topics

Disease

15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 08/2007
12	Neoplasms (Cancer) 04/2023 - 05/2005
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2006
8	Lymphoma (Lymphomas) 01/2021 - 01/2006
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2021 - 05/2009
5	B-Cell Lymphoma (Lymphoma, B Cell) 04/2021 - 01/2008
5	Breast Neoplasms (Breast Cancer) 05/2020 - 01/2006
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 05/2012
3	Neutropenia 04/2021 - 01/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2019 - 04/2009
3	Infections 11/2017 - 12/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 04/2009
2	Febrile Neutropenia 04/2021 - 11/2017
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2020 - 07/2014
2	Fever (Fevers) 02/2020 - 11/2017
2	Multiple Myeloma 01/2020 - 05/2014
2	Anemia 05/2014 - 01/2013
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2013 - 11/2007
2	Stomatitis 09/2012 - 05/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2012 - 05/2011
2	Neuroendocrine Carcinoma 08/2012 - 05/2005
1	Hematologic Neoplasms (Hematological Malignancy) 12/2015
1	Hodgkin Disease (Hodgkin's Disease) 07/2014
1	Tumor Lysis Syndrome 05/2014
1	Thrombotic Thrombocytopenic Purpura 11/2013
1	Thrombocytopenia (Thrombopenia) 11/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2013
1	Esophageal Neoplasms (Esophageal Cancer) 09/2012
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Anorexia 04/2012
1	Nausea 04/2012
1	Diarrhea 04/2012
1	Abdominal Pain (Pain, Abdominal) 04/2012
1	Fatigue 04/2012
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2008

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 01/2021 - 01/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 05/2008
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 05/2008
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 05/2008
4	Cisplatin (Platino)FDA LinkGeneric 08/2012 - 05/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2021 - 11/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2021 - 05/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 08/2010
3	Docetaxel (Taxotere)FDA Link 05/2011 - 05/2005
3	Complement System Proteins (Complement)IBA 05/2009 - 01/2006
2	tirabrutinibIBA 04/2023 - 05/2019
2	Agammaglobulinaemia Tyrosine KinaseIBA 04/2023 - 05/2019
2	obinutuzumabIBA 11/2021 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 11/2013
2	Bortezomib (Velcade)FDA Link 01/2020 - 05/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2015 - 10/2013
2	LactaseIBA 05/2014 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 05/2014 - 01/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2014 - 01/2013
2	Thymidine KinaseIBA 11/2013 - 05/2012
2	AntibodiesIBA 01/2013 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 01/2006 - 06/2004
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Bendamustine Hydrochloride FDA Link 01/2022
1	polatuzumab vedotinIBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 05/2019
1	Immunoglobulin G (IgG)IBA 02/2018
1	Immunoglobulins (Immunoglobulin)IBA 02/2018
1	R-CHOP protocolIBA 11/2017
1	Brentuximab VedotinIBA 07/2014
1	AlbuminsIBA 05/2014
1	CreatinineIBA 05/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013
1	Heparin (Liquaemin)FDA LinkGeneric 11/2013
1	PlatinumIBA 11/2013
1	SaltsIBA 11/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2013
1	ofatumumab FDA Link 05/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2012
1	Epidermal Growth Factor (EGF)IBA 04/2012
1	neratinibIBA 04/2012
1	AlginatesIBA 05/2011
1	SuspensionsIBA 05/2011
1	SolutionsIBA 05/2011
1	polaprezinc (Z 103)IBA 05/2011
1	Fluorouracil (Carac)FDA LinkGeneric 05/2011
1	Inotuzumab OzogamicinIBA 08/2010
1	CalicheamicinsIBA 08/2010
1	Sialic Acid Binding Ig-like Lectin 2IBA 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 04/2009

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2017 - 05/2005
12	Therapeutics 11/2021 - 01/2006
2	Drug Tapering 04/2021 - 09/2012
2	Radiotherapy 09/2012 - 05/2010
2	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 01/2008
1	VAP-cyclo protocol 01/2021
1	Breast Implants (Breast Implant) 05/2020
1	Adjuvant Chemotherapy 10/2013
1	Salvage Therapy 01/2013